
Ichi chinyorwa chinopa mucherechedzo wekufambira mberi kwakakosha mu kurapwa kutsva kwegomarara remapapu kubudirira 2020 uye mberi. Isu tinoongorora zviitiko zvakakosha mukurapa kwakanangwa, immunotherapies, uye dzimwe nzira nyowani, tichitarisa pakubudirira kwavo uye zvinogona kukanganisa mhedzisiro yemurwere. Dzidza nezve tsvagiridzo yazvino uye miedzo yekiriniki inoenderera mberi inoumba ramangwana rekuchengeta kenza yemapapu.
Kufambira mberi kwakakosha kwakaitwa mukurapa kwakanangwa, kunyanya kune varwere vane genetic mutations. Kurapa kutsva kwekenza yemapapu kurapa 2020 yakaona kubvumidzwa kwevanoverengeka mitsva EGFR uye ALK inhibitors, ichipa kuvandudza kushanda uye kushivirira zvichienzaniswa nezvizvarwa zvekare. Mishonga iyi inonangana nemaseru egomarara nekuchinja uku, kuderedza kukuvadzwa kune hutano. Semuenzaniso, kugadzirwa kweyechitatu-chizvarwa EGFR inhibitors kwakaratidza kuvimbiswa mukukunda kuramba kurapwa kwepakutanga. Kumwe kutsvagurudza kunoenderera mberi nekuongorora kugona kweaya anonangwa marapirwo pamwe chete nemamwe marapirwo.
Immunotherapies, iyo inoshandisa immune system yemuviri kurwisa cancer, yachinja kurapwa kutsva kwegomarara remapapu kubudirira 2020. Checkpoint inhibitors, senge PD-1 uye PD-L1 inhibitors, yakaratidza kubudirira kunoshamisa mukuwedzera kurarama muvarwere vane kenza yemapapu yepamusoro. Mishonga iyi inovhara masaini anoshandiswa nemasero egomarara kunzvenga immune system, achibvumira masero edziviriro kurwisa nekuparadza bundu. Nekudaro, havazi vese varwere vanopindura immunotherapy, uye tsvagiridzo irikuenderera mberi yekuona ma biomarkers kufanotaura kuti ndevapi varwere vanonyanya kubatsirwa. Kupfuurirazve, zvidzidzo zviri kuongorora kushandiswa kweimmunotherapy mukubatana nemamwe marapirwo, senge chemotherapy kana kurapa kwakanangwa, kwekuwedzera kushanda.
Kupfuura kurapwa kwakanangwa uye immunotherapies, dzimwe nzira dzakati wandei dzinovimbisa dziri kuongororwa. kurapwa kutsva kwegomarara remapapu kubudirira 2020. Izvi zvinosanganisira novel chemotherapy regimens, kufambira mberi kweradiation therapy (senge stereotactic body radiotherapy kana SBRT), uye masystem matsva ekuunza zvinodhaka. Zviyedzo zvakawanda zvekiriniki zviri kuitika, kuongorora kushanda kwemishonga mitsva iyi uye kuongorora zvingangosanganiswa kuti zvinyatsobuda. Kugara uchiziva nezvezviyedzo zvekiriniki zvinoenderera mberi kwakakosha kune varwere nemhuri dzavo vari kutsvaga nzira dzepamusoro dzekurapa. ClinicalTrials.gov inzvimbo yakakosha yekutsvaga ruzivo rwezviedzo zvazvino.
Mamiriro ekurapa cancer yemapapu ari kuramba achishanduka, nekutsvagisa kuri kuramba kuchienderera mberi nekusundira miganhu yezvinogoneka. Iko kubatanidzwa kweiyo chaiyo mushonga, immunotherapy, uye dzimwe nzira dzekuvandudza zvine vimbiso huru yekuvandudza mhedzisiro yevarwere uye huwandu hwekupona. Izvo zvakakosha kuti vanhu vakatarisana nechirwere chegomarara remapapu vabvunze oncologist wavo kuti vakurukure nzira yekurapa yakanyatsoenderana nemamiriro avo chaiwo uye genetic profile. Kuti uwane hutano hwakakwana hwegomarara, funga kuongorora hunyanzvi huripo kumasangano akaita se Shandong Baofa Cancer Research Institute.
| Kurapa Type | Kufambira Mberi Kwakakosha | Mhedzisiro paMigumisiro Yemurwere |
|---|---|---|
| EGFR Inhibitors | Chechitatu-chizvarwa inhibitors (semuenzaniso, osimertinib) | Kuvandudzwa kwekufambira mberi-kusina kupona uye kurarama kwese mune dzimwe varwere. |
| Immunotherapy (PD-1/PD-L1 inhibitors) | Kuwedzera kushandiswa mumagadzirirwo ekurapa ekutanga. | Kuvandudzwa kwakakosha muhuwandu hwekupona kune chaiwo mapoka evarwere. |
Cherechedzo: Ruzivo urwu nderweruzivo rwakakwana uye zvinangwa zveruzivo chete, uye haruunze zano rekurapa. Gara uchibvunzurudza nenyanzvi yezvehutano ine ruzivo rwezvehutano kana usati waita chero sarudzo dzine chekuita nehutano hwako kana kurapwa.
p>
parutivi>
body>